Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53

Molecules and Cells

Volumn 22, Issue 2, 2006, Pages 133-140

  Lee, Eun Woo ^a   Oh, Wonkyung ^a   Song, Jaewhan ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

CNS; Jab1; JAMM

Indexed keywords

EXPORTIN 1; PROTEIN MDM2; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JAB1; UNCLASSIFIED DRUG; CELL RECEPTOR; COPS5 PROTEIN, HUMAN; EXPORTIN 1 PROTEIN; KARYOPHERIN; PEPTIDE HYDROLASE; SIGNAL PEPTIDE;

APOPTOSIS; CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL NUCLEUS; CELLULAR DISTRIBUTION; CORRELATION ANALYSIS; CYTOPLASM; GENETIC CODE; GENOTOXICITY; HEMOSTASIS; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEAR EXPORT SIGNAL; ONCOGENE; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SHORT SURVEY; STEADY STATE; UBIQUITINATION; ACTIVE TRANSPORT; ANIMAL; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

MIRIDAE; WEST NILE VIRUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CYTOPLASM; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KARYOPHERINS; PEPTIDE HYDROLASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33847689863     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (59)

1. Ambroggio, X. I., Rees, D. C., and Deshaies, R. J. (2004) JAMM: a metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biol. 2, E2.
2. Bae, M. K., Ahn, M. Y., Jeong, J. W., Bae, M. H., Lee, Y. M., et al. (2002) Jab1 interacts directly with HIF-1alpha and regulates its stability. J. Biol. Chem. 277, 9-12.
3. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., et al. (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20, 1630-1639.
4. Bernardi, R., Scaglioni, P. P., Bergmann, S., Horn, H. F., Vousden, K. H., et al. (2004) PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell. Biol. 6, 665-672.
5. Bianchi, E., Denti, S., Granata, A., Bossi, G., Geginat, J., et al. (2000) Integrin LFA-1 interacts with the transcriptional coactivator JAB1 to modulate AP-1 activity. Nature 404, 617-621.
6. Bode, A. M. and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793-805.
7. Boyd, S. D., Tsai, K. Y., and Jacks, T. (2000) An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell. Biol. 2, 563-568.
8. Brooks, C. L., Li, M., and Gu, W. (2004) Monoubiquitination: the signal for p53 nuclear export? Cell Cycle 3, 436-438.
9. Callige, M., Kieffer, I., and Richard-Foy, H. (2005) CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. Mol. Cell. Biol. 25, 4349-4358.
10. Chamovitz, D. A., Wei, N., Osterlund, M. T., von Arnim, A. G., Staub, J. M., et al. (1996) The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell 86, 115-121.
11. Chauchereau, A., Georgiakaki, M., Perrin-Wolff, M., Milgrom, E., and Loosfelt, H. (2000) JAB1 interacts with both the progesterone receptor and SRC-1. J Biol Chem, 275, 8540-8548.
12. Claret, F. X., Hibi, M., Dhut, S., Toda, T., and Karin, M. (1996) A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383, 453-457.
13. Cope, G. A. and Deshaies, R. J. (2006) Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels. BMC Biochem. 7, 1.
14. Cope, G. A., Suh, G. S., Aravind, L., Schwarz, S. E., Zipursky, S. L., et al. (2002) Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 298, 608-611.
15. Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., et al. (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92.
16. Doronkin, S., Djagaeva, I., and Beckendorf, S. K. (2003) The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis. Dev. Cell 4, 699-710.
17. Freedman, D. A. and Levine, A. J. (1998) Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288-7293.
18. Geyer, R. K., Yu, Z. K., and Maki, C. G. (2000) The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell. Biol. 2, 569-573.
19. Gronroos, E., Terentiev, A. A., Punga, T., and Ericsson, J. (2004) YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc. Natl. Acad. Sci. USA 101, 12165-12170.
20. Grossman, S. R., Deato, M. E., Brignone, C., Chan, H. M., Kung, A. L., et al. (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342-344.
21. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
22. Kim, B. C., Lee, H. J., Park, S. H., Lee, S. R., Karpova, T. S., et al. (2004) Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol. Cell. Biol. 24, 2251-2262.
23. Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger-Kentischer, A., et al. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408, 211-216.
24. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. (1997) Regulation of p53 stability by Mdm2. Nature 387, 299-303.
25. Lane, D. P. (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16.
26. Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., et al. (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112, 779-791.
27. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
28. Levinson, H., Sil, A. K., Conwell, J. E., Hopper, J. E., and Ehrlich, H. P. (2004) Alpha V integrin prolongs collagenase production through Jun activation binding protein 1. Ann. Plast. Surg. 53, 155-161.
29. Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., et al. (2003) Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975.
30. Li, S., Liu, X., and Ascoli, M. (2000) p38JAB1 binds to the intracellular precursor of the lutropin/choriogonadotropin receptor and promotes its degradation. J. Biol. Chem. 275, 13386-13393.
31. Louria-Hayon, I., Grossman, T., Sionov, R. V., Alsheich, O., Pandolfi, P. P., et al. (2003) The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J. Biol. Chem. 278, 33134-33141.
32. Lu, C., Li, Y., Zhao, Y., Xing, G., Tang, F., et al. (2002) Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway. FASEB J. 16, 90-92.
33. Lyapina, S., Cope, G., Shevchenko, A., Serino, G., Tsuge, T., et al. (2001) Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292, 1382-1385.
34. O'Brate, A. and Giannakakou, P. (2003) The importance of p53 location: nuclear or cytoplasmic zip code? Drug Resist. Updat. 6, 313-322.
35. Oh, W., Lee, E. W., Sung, Y. H., Yang, M. R., Ghim, J., et al. (2006a) Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J. Biol. Chem. 281, 17457-17465.
36. Oh, W., Yang, M. R., Lee, E. W., Park, K. M., Pyo, S., et al. (2006b) Jab1 mediates cytoplasmic localization and degradation of West Nile Virus capsid protein. J. Biol. Chem. (in press).
37. Querido, E., Blanchette, P., Yan, Q., Kamura, T., Morrison, M., et al. (2001) Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15, 3104-3117.
38. Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., and Levine, A. J. (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564.
39. Sherr, C. J. and Weber, J. D. (2000) The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94-99.
40. Shirangi, T. R., Zaika, A., and Moll, U. M. (2002) Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J. 16, 420-422.
41. Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., et al. (1996) MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15, 5349-5357.
42. Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., et al. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672.
43. Sui, G., Affar el, B., Shi, Y., Brignone, C., Wall, N. R., et al. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117, 859-872.
44. Tanaka, Y., Kanai, F., Ichimura, T., Tateishi, K., Asaoka, Y., et al. (2006) The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 25, 633-642.
45. Tomoda, K., Kubota, Y., Arata, Y., Mori, S., Maeda, M., et al. (2002) The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277, 2302-2310.
46. Tomoda, K., Kubota, Y., and Kato, J. (1999) Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398, 160-165.
47. Tomoda, K., Yoneda-Kato, N., Fukumoto, A., Yamanaka, S., and Kato, J. Y. (2004) Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J. Biol. Chem. 279, 43013-43018.
48. Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R., 3rd, et al. (2002) Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298, 611-615.
49. Vousden, K. H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604.
50. Wan, M., Cao, X., Wu, Y., Bai, S., Wu, L., et al. (2002) Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep. 3, 171-176.
51. Wang, Y., Lu, C., Wei, H., Wang, N., Chen, X., et al. (2004a) Hepatopoietin interacts directly with COP9 signalosome and regulates AP-1 activity. FEBS Lett. 572, 85-91.
52. Wang, Z. Q., Wei, H. D., and He, F. C. (2004b) Protein product encoded by a human novel gene E9730 enhances AP-1 activity through interacting with Jab1. Acta Biochim. Biophys. Sin (Shanghai) 36, 11-15.
53. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D. (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell. Biol. 1, 20-26.
54. Wei, N., Chamovitz, D. A., and Deng, X. W. (1994) Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development. Cell 78, 117-124.
55. Wei, N. and Deng, X. W. (1999) Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet. 15, 98-103.
56. Woods, D. B. and Vousden, K. H. (2001) Regulation of p53 function. Exp. Cell. Res. 264, 56-66.
57. Yang, X., Menon, S., Lykke-Andersen, K., Tsuge, T., Di, X., et al. (2002) The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1. Curr. Biol. 12, 667-672.
58. Yang, Y., Li, C. C., and Weissman, A. M. (2004) Regulating the p53 system through ubiquitination. Oncogene 23, 2096-2106.
59. Yu, Z. K., Geyer, R. K., and Maki, C. G. (2000) MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene 19, 5892-5897.